| 2025年年报 | 2024年年报 | |
|---|---|---|
| 营业收入(元) | ||
| CDMO(元) | 84,101,208.48 | 121,707,818.30 |
| 贸易类(元) | 26,083,495.45 | 48,358,520.42 |
| 原料药及中间体(元) | 769,002,242.29 | 792,657,971.97 |
| 制剂类(元) | 611,902,056.32 | 405,469,948.85 |
| 营业成本(元) | ||
| CDMO(元) | 41,319,130.83 | 82,945,888.84 |
| 贸易类(元) | 20,494,749.14 | 38,611,847.90 |
| 原料药及中间体(元) | 553,417,498.69 | 532,739,317.37 |
| 制剂类(元) | 357,522,527.41 | 267,032,952.68 |
| 毛利(元) | ||
| CDMO(元) | 42,782,077.65 | 38,761,929.46 |
| 贸易类(元) | 5,588,746.31 | 9,746,672.52 |
| 原料药及中间体(元) | 215,584,743.60 | 259,918,654.60 |
| 制剂类(元) | 254,379,528.91 | 138,436,996.17 |
| 毛利率(%) | ||
| CDMO(%) | 50.87 | 31.85 |
| 贸易类(%) | 21.43 | 20.16 |
| 原料药及中间体(%) | 28.03 | 32.79 |
| 制剂类(%) | 41.57 | 34.14 |
| 收入构成(%) | ||
| CDMO(%) | 5.64 | 8.90 |
| 贸易类(%) | 1.75 | 3.53 |
| 原料药及中间体(%) | 51.57 | 57.93 |
| 制剂类(%) | 41.04 | 29.64 |
| 毛利构成(%) | ||
| CDMO(%) | 8.25 | 8.67 |
| 贸易类(%) | 1.08 | 2.18 |
| 原料药及中间体(%) | 41.59 | 58.17 |
| 制剂类(%) | 49.08 | 30.98 |